WeVote

Bill

Bill

HB 602

RELATING TO THE MEDICAL USE OF CANNABIS.

2026 Regular Session Introduced by Diamond Garcia

Hawaii HB 602 modifies medical cannabis regulations, referred to health, commerce, and finance committees, affecting patient access and state oversight of the cannabis program.

Carried over to 2026 Regular Session.
0
WeVote Research Nonpartisan
Bill Summary · HB 602

Legislative bill overview

HB 602 relates to the medical use of cannabis in Hawaii, though the specific provisions are not detailed in the available information. The bill was introduced by Representative Diamond Garcia and has progressed through initial legislative steps before being carried over to the 2026 session. It has been referred to the Health (HLT), Consumer Protection and Commerce (CPC/JHA), and Finance (FIN) committees.

Why is this important

Medical cannabis legislation affects patient access to treatment options, healthcare provider regulations, and state revenue. Hawaii's approach to medical cannabis impacts thousands of patients currently enrolled in the state's medical cannabis program and shapes the broader regulatory framework for cannabis use in the state.

Potential points of contention

  • Program expansion vs. fiscal concerns: The bill's referral to the Finance Committee suggests potential cost implications; debates may center on whether expanded access strains state budgets or licensing requirements increase regulatory costs
  • Patient access and qualifying conditions: Disagreement likely exists over which medical conditions should qualify for medical cannabis and whether current restrictions should be broadened or maintained
  • Regulatory oversight and business licensing: Questions may arise about how strictly to regulate dispensaries, growers, and manufacturers, and whether regulations adequately protect consumers while supporting the legal market

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.